Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.35 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.54.
Market Cap
8.35T
Revenue
4.59T
Profits
201.03B
PE Ratio
41.54
Profit Margin
4.38%
Dividend Yield
0.43%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 980.02B | -1.17% | 2,223,289 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 550.24B | -2.40% | 7,284,005 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 382.16B | -2.23% | 3,912,822 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 366.45B | 1.00% | 4,143,367 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 281.96B | -1.11% | 9,533,911 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 279.89B | -1.65% | 1,260,837 | 60.44B |
| 7 | NVS | Novartis AG | 279.26B | -2.37% | 1,193,633 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 190.50B | -1.24% | 6,255,285 | 50.57B |
| 9 | AMGN | Amgen Inc. | 180.89B | -1.90% | 2,579,810 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 173.49B | 1.12% | 1,340,679 | 45.20B |
| 11 | ABT | Abbott Laboratories | 153.63B | -0.34% | 6,460,768 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 152.76B | -1.93% | 4,314,059 | 29.74B |
| 13 | PFE | Pfizer Inc. | 144.20B | -2.39% | 56,599,476 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 143.71B | 0.89% | 1,835,309 | 10.58B |
| 15 | DHR | Danaher Corporation | 125.71B | -0.08% | 2,430,085 | 24.78B |
| 16 | CVS | CVS Health Corporation | 125.51B | -0.80% | 5,695,067 | 405.62B |
| 17 | SYK | Stryker Corporation | 119.22B | 3.27% | 1,695,490 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 114.85B | -1.41% | 1,259,770 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 110.11B | -2.46% | 8,753,120 | 48.48B |
| 20 | SNY | Sanofi | 104.18B | -0.75% | 2,913,200 | 54.60B |
| 21 | GSK | GSK plc | 101.61B | -2.53% | 2,742,017 | 43.29B |
| 22 | MDT | Medtronic plc | 101.54B | 1.22% | 5,675,184 | 36.36B |
| 23 | MCK | McKesson Corporation | 87.64B | -4.01% | 907,266 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 84.21B | -0.89% | 854,679 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.20B | -3.38% | 1,058,877 | 76.39B |
| 26 | CI | The Cigna Group | 74.29B | -1.50% | 905,637 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 67.42B | 0.91% | 18,139,775 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 61.34B | -0.83% | 587,491 | 14.92B |
| 29 | ARGX | argenx SE | 56.24B | -1.26% | 260,833 | 4.74B |
| 30 | COR | Cencora, Inc. | 52.55B | -2.53% | 1,188,099 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 51.98B | -1.92% | 1,711,389 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 49.95B | 0.08% | 2,016,137 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.43B | 1.07% | 1,508,797 | 28.34B |
| 34 | MDLN | Medline Inc. | 46.82B | -2.14% | 6,009,155 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.06B | 2.29% | 316,535 | 4.45B |
| 36 | HUM | Humana Inc. | 43.81B | 0.80% | 780,904 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 39.67B | 1.66% | 1,743,695 | 22.23B |
| 38 | HLN | Haleon plc | 39.15B | 0.90% | 15,044,309 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 36.96B | -2.08% | 930,400 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 36.48B | -3.79% | 7,964,355 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 35.95B | 2.36% | 1,447,432 | 7.23B |
| 42 | WAT | Waters Corporation | 34.87B | -0.51% | 458,331 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 34.31B | 2.28% | 1,691,509 | - |
| 44 | NTRA | Natera, Inc. | 32.91B | 1.48% | 648,769 | 2.50B |
| 45 | ZTS | Zoetis Inc. | 32.87B | 1.48% | 6,526,695 | 9.53B |
| 46 | ALC | Alcon Inc. | 31.51B | 0.86% | 1,432,330 | 10.63B |
| 47 | CNC | Centene Corporation | 30.33B | 1.29% | 3,032,596 | 178.33B |
| 48 | RPRX | Royalty Pharma plc | 30.13B | -2.57% | 2,316,511 | 2.44B |
| 49 | ONC | BeOne Medicines AG | 29.84B | 2.18% | 244,606 | 5.70B |
| 50 | BIIB | Biogen Inc. | 28.84B | -1.68% | 540,993 | 9.94B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 27.85B | 0.11% | 3,721,640 | 20.98B |
| 52 | DXCM | DexCom, Inc. | 27.83B | 1.27% | 2,501,196 | 4.82B |
| 53 | IQV | IQVIA Holdings Inc. | 27.82B | -2.33% | 1,954,413 | 16.63B |
| 54 | RMD | ResMed Inc. | 27.09B | 0.70% | 1,195,141 | 5.54B |
| 55 | PHG | Koninklijke Philips N.V. | 25.68B | 1.87% | 1,187,354 | 20.34B |
| 56 | MRNA | Moderna, Inc. | 25.43B | 3.72% | 12,697,039 | 2.23B |
| 57 | VEEV | Veeva Systems Inc. | 24.76B | -1.56% | 1,534,237 | 3.32B |
| 58 | ILMN | Illumina, Inc. | 24.51B | 1.82% | 682,705 | 4.39B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.19B | 1.61% | 111,125 | 4.09B |
| 60 | BNTX | BioNTech SE | 23.09B | -1.01% | 523,578 | 3.23B |
| 61 | WST | West Pharmaceutical Services, Inc. | 23.08B | 0.96% | 465,274 | 3.22B |
| 62 | UTHR | United Therapeutics Corporation | 22.93B | -2.06% | 299,894 | 3.17B |
| 63 | ROIV | Roivant Sciences Ltd. | 22.38B | -0.26% | 3,111,799 | 8.26M |
| 64 | DGX | Quest Diagnostics Incorporated | 21.46B | -1.97% | 513,327 | 11.28B |
| 65 | LH | Labcorp Holdings Inc. | 20.93B | -1.64% | 463,514 | 14.14B |
| 66 | INSM | Insmed Incorporated | 20.53B | -3.80% | 4,497,741 | 819.56M |
| 67 | STE | STERIS plc | 19.66B | 1.15% | 823,158 | 5.94B |
| 68 | INCY | Incyte Corporation | 19.43B | -1.77% | 990,334 | 5.36B |
| 69 | VTRS | Viatris Inc. | 17.76B | -3.05% | 9,021,198 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.46B | 1.99% | 1,276,277 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.07B | 1.26% | 868,907 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 15.76B | -1.40% | 430,890 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.60B | -0.28% | 1,115,683 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 14.89B | -3.13% | 625,236 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 14.35B | -0.07% | 446,387 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.04B | -1.41% | 531,856 | 4.44B |
| 77 | BTSG | BrightSpring Health Services, Inc. | 13.73B | 2.33% | 1,659,786 | 13.65B |
| 78 | DVA | DaVita Inc. | 13.42B | -0.76% | 401,374 | 13.84B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.09B | 0.27% | 169,130 | 2.68B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 13.05B | -1.11% | 1,697,646 | 579.96M |
| 81 | EXEL | Exelixis, Inc. | 13.03B | -1.13% | 1,374,808 | 2.38B |
| 82 | SOLV | Solventum Corporation | 13.01B | 0.75% | 743,693 | 8.26B |
| 83 | ALGN | Align Technology, Inc. | 12.91B | 3.91% | 449,983 | 4.10B |
| 84 | SNN | Smith & Nephew plc | 12.85B | -0.10% | 771,153 | 6.16B |
| 85 | COO | The Cooper Companies, Inc. | 12.84B | 1.23% | 1,400,817 | 4.23B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.83B | -1.10% | 360,598 | 708.24M |
| 87 | FMS | Fresenius Medical Care AG | 12.70B | 0.02% | 308,822 | 22.32B |
| 88 | PEN | Penumbra, Inc. | 12.45B | 0.10% | 170,477 | 1.45B |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 12.26B | -0.16% | 527,143 | 1.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.98B | 2.57% | 2,912,961 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.57B | 0.41% | 274,776 | 1.13B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.44B | 0.23% | 1,190,797 | 622.01M |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.20B | 0.57% | 932,989 | 3.58B |
| 94 | RVTY | Revvity, Inc. | 11.13B | 2.03% | 480,355 | 2.90B |
| 95 | ICLR | ICON Public Limited Company | 11.05B | 0.75% | 403,773 | 8.25B |
| 96 | SMMT | Summit Therapeutics Inc. | 10.69B | -2.13% | 3,103,585 | - |
| 97 | GMED | Globus Medical, Inc. | 10.67B | 4.27% | 1,143,296 | 3.10B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 10.61B | -0.24% | 949,635 | 3.24B |
| 99 | CYTK | Cytokinetics, Incorporated | 10.59B | -0.18% | 1,383,599 | 105.82M |
| 100 | BAX | Baxter International Inc. | 10.27B | 2.53% | 3,879,834 | 11.32B |
| 101 | KRYS | Krystal Biotech, Inc. | 10.21B | 1.33% | 213,429 | 417.30M |
| 102 | MOH | Molina Healthcare, Inc. | 10.15B | -0.35% | 260,538 | 43.10B |
| 103 | PODD | Insulet Corporation | 9.99B | 0.46% | 660,429 | 2.90B |
| 104 | NUVL | Nuvalent, Inc. | 9.75B | 0.03% | 2,982,026 | - |
| 105 | EHC | Encompass Health Corporation | 9.64B | -0.75% | 593,825 | 6.07B |
| 106 | HSIC | Henry Schein, Inc. | 9.10B | -0.09% | 704,780 | 13.38B |
| 107 | TECH | Bio-Techne Corporation | 9.03B | 4.89% | 1,568,593 | 1.21B |
| 108 | TEM | Tempus AI, Inc. | 8.93B | 1.97% | 3,028,667 | 1.36B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.93B | 1.65% | 350,880 | 4.03B |
| 110 | ENSG | The Ensign Group, Inc. | 8.84B | -2.12% | 724,955 | 5.27B |
| 111 | BRKR | Bruker Corporation | 8.65B | 3.87% | 750,052 | 3.46B |
| 112 | CORT | Corcept Therapeutics Incorporated | 8.56B | -2.41% | 559,547 | 769.10M |
| 113 | UHS | Universal Health Services, Inc. | 8.51B | -0.43% | 836,614 | 17.76B |
| 114 | OSCR | Oscar Health, Inc. | 8.39B | -1.49% | 3,844,472 | 13.30B |
| 115 | HIMS | Hims & Hers Health, Inc. | 8.15B | 10.44% | 23,031,912 | 2.37B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.06B | -0.88% | 1,275,723 | 1.51B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 7.89B | 4.83% | 225,551 | 7.46M |
| 118 | ABVX | ABIVAX Société Anonyme | 7.88B | -1.05% | 1,311,626 | 5.67M |
| 119 | ATR | AptarGroup, Inc. | 7.67B | 0.21% | 272,066 | 3.87B |
| 120 | QGEN | Qiagen N.V. | 7.65B | 1.09% | 1,156,643 | 2.10B |
| 121 | GKOS | Glaukos Corporation | 7.61B | 1.74% | 316,007 | 551.35M |
| 122 | SYRE | Spyre Therapeutics, Inc. | 7.56B | -0.45% | 1,075,161 | - |
| 123 | BIO | Bio-Rad Laboratories, Inc. | 7.56B | -0.76% | 144,154 | 2.59B |
| 124 | IBRX | ImmunityBio, Inc. | 7.50B | 2.43% | 5,674,229 | 140.98M |
| 125 | PCVX | Vaxcyte, Inc. | 7.44B | 1.66% | 902,128 | - |
| 126 | KYMR | Kymera Therapeutics, Inc. | 7.42B | 0.29% | 570,917 | 51.48M |
| 127 | RGEN | Repligen Corporation | 7.41B | -1.68% | 654,853 | 763.34M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.40B | 1.42% | 1,315,578 | 700.35M |
| 129 | ALKS | Alkermes plc | 7.36B | -0.79% | 947,910 | 1.56B |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 7.20B | 0.49% | 462,297 | 74.06M |
| 131 | IMVT | Immunovant, Inc. | 7.16B | 0.40% | 917,472 | - |
| 132 | HQY | HealthEquity, Inc. | 7.10B | -1.56% | 515,640 | 1.34B |
| 133 | LNTH | Lantheus Holdings, Inc. | 6.76B | 0.61% | 310,794 | 1.55B |
| 134 | APGE | Apogee Therapeutics, Inc. | 6.74B | 1.65% | 557,666 | - |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.70B | 2.00% | 946,372 | 217.17M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 6.56B | 5.39% | 668,516 | 569.61M |
| 137 | AVTR | Avantor, Inc. | 6.53B | 1.16% | 3,584,995 | 6.55B |
| 138 | PTCT | PTC Therapeutics, Inc. | 6.52B | 0.17% | 900,038 | 827.11M |
| 139 | GRFS | Grifols, S.A. | 6.27B | -1.01% | 335,679 | 8.58B |
| 140 | LQDA | Liquidia Corporation | 6.24B | 2.14% | 1,489,930 | 288.07M |
| 141 | CNTA | Centessa Pharmaceuticals plc | 6.19B | 0.36% | 3,993,231 | 15.00M |
| 142 | RGC | Regencell Bioscience Holdings Limited | 6.15B | -16.19% | 284,318 | - |
| 143 | COGT | Cogent Biosciences, Inc. | 5.86B | 1.78% | 1,971,332 | - |
| 144 | CHE | Chemed Corporation | 5.78B | 0.32% | 165,702 | 2.54B |
| 145 | BLTE | Belite Bio, Inc | 5.72B | -1.96% | 181,529 | - |
| 146 | PACS | PACS Group, Inc. | 5.70B | 2.16% | 494,160 | 5.43B |
| 147 | SRRK | Scholar Rock Holding Corporation | 5.62B | -0.17% | 693,684 | - |
| 148 | TFX | Teleflex Incorporated | 5.59B | 1.06% | 171,127 | 2.13B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 5.41B | 2.61% | 284,719 | 274.48M |
| 150 | BLCO | Bausch + Lomb Corporation | 5.31B | 0.20% | 162,762 | 5.21B |
| 151 | HNGE | Hinge Health, Inc. | 5.30B | 2.22% | 598,839 | 646.34M |
| 152 | CGON | CG Oncology, Inc. | 5.29B | -0.66% | 538,132 | 5.07M |
| 153 | TWST | Twist Bioscience Corporation | 5.28B | 2.31% | 1,204,386 | 409.48M |
| 154 | CAI | Caris Life Sciences, Inc. | 5.20B | 3.08% | 956,913 | 907.29M |
| 155 | LEGN | Legend Biotech Corporation | 5.15B | -17.30% | 10,846,761 | 1.14B |
| 156 | CRSP | CRISPR Therapeutics AG | 5.15B | 0.55% | 823,380 | 4.10M |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.14B | -1.04% | 890,133 | 3.05B |
| 158 | XENE | Xenon Pharmaceuticals Inc. | 5.12B | -0.38% | 1,187,359 | 7.50M |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.04B | 0.20% | 1,317,069 | 536.20M |
| 160 | BLLN | BillionToOne, Inc. | 4.81B | 5.16% | 397,790 | 354.54M |
| 161 | STVN | Stevanato Group S.p.A. | 4.77B | 2.37% | 107,347 | 1.39B |
| 162 | ALHC | Alignment Healthcare, Inc. | 4.51B | 1.87% | 2,957,963 | 4.26B |
| 163 | DNTH | Dianthus Therapeutics, Inc. | 4.47B | -0.06% | 529,347 | 1.34M |
| 164 | SHC | Sotera Health Company | 4.47B | 1.29% | 1,033,716 | 1.19B |
| 165 | TXG | 10x Genomics, Inc. | 4.40B | 7.87% | 2,201,185 | 638.78M |
| 166 | ORKA | Oruka Therapeutics, Inc. | 4.39B | 2.78% | 742,559 | - |
| 167 | ERAS | Erasca, Inc. | 4.34B | -0.14% | 4,178,828 | - |
| 168 | LIVN | LivaNova PLC | 4.29B | -0.59% | 435,547 | 1.43B |
| 169 | CELC | Celcuity Inc. | 4.26B | -0.73% | 1,000,227 | - |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.26B | 2.07% | 405,431 | 754.05M |
| 171 | RDNT | RadNet, Inc. | 4.23B | 1.76% | 853,779 | 2.14B |
| 172 | VCYT | Veracyte, Inc. | 4.21B | 2.77% | 687,477 | 541.74M |
| 173 | NVST | Envista Holdings Corporation | 4.20B | 3.70% | 1,129,794 | 2.81B |
| 174 | TNGX | Tango Therapeutics, Inc. | 4.09B | -12.36% | 8,083,916 | 56.99M |
| 175 | MMED | MiniMed Group, Inc. | 4.06B | 2.12% | 265,368 | 3.10B |
| 176 | MMSI | Merit Medical Systems, Inc. | 4.01B | 2.99% | 470,329 | 1.54B |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 3.94B | 5.11% | 1,257,968 | - |
| 178 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.03% | 1,769,691 | 596.96M |
| 179 | MANE | Veradermics, Incorporated | 3.76B | -1.93% | 348,451 | - |
| 180 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.75B | -0.50% | 426,392 | 18.07M |
| 181 | DOCS | Doximity, Inc. | 3.75B | 0.15% | 1,994,813 | 644.86M |
| 182 | DNLI | Denali Therapeutics Inc. | 3.72B | -0.17% | 1,332,157 | - |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 3.66B | 0.88% | 425,233 | 2.23B |
| 184 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | -1.57% | 826,254 | 1.10B |
| 185 | VKTX | Viking Therapeutics, Inc. | 3.56B | 1.29% | 850,107 | - |
| 186 | ICUI | ICU Medical, Inc. | 3.53B | 2.49% | 189,086 | 2.16B |
| 187 | WAY | Waystar Holding Corp. | 3.52B | 0.66% | 1,699,751 | 1.16B |
| 188 | OGN | Organon & Co. | 3.52B | -0.07% | 1,608,153 | 6.16B |
| 189 | LFST | LifeStance Health Group, Inc. | 3.52B | 5.34% | 2,698,219 | 1.49B |
| 190 | RLAY | Relay Therapeutics, Inc. | 3.51B | 3.47% | 1,977,359 | 10.68M |
| 191 | NAMS | NewAmsterdam Pharma Company N.V. | 3.49B | -1.03% | 866,189 | 22.57M |
| 192 | OPCH | Option Care Health, Inc. | 3.46B | 1.61% | 1,675,403 | 5.67B |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.44B | 1.01% | 47,395 | 803.79M |
| 194 | IRTC | iRhythm Holdings, Inc. | 3.40B | 1.71% | 289,550 | 787.85M |
| 195 | HAE | Haemonetics Corporation | 3.37B | 2.03% | 392,114 | 1.33B |
| 196 | BEAM | Beam Therapeutics Inc. | 3.36B | 3.85% | 1,037,103 | 164.01M |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.35B | 0.96% | 340,308 | - |
| 198 | BKD | Brookdale Senior Living Inc. | 3.28B | 0.77% | 1,668,328 | 3.00B |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.22B | -1.68% | 1,062,990 | 415.62M |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.20B | 0.83% | 1,930,741 | - |
| 201 | GPCR | Structure Therapeutics Inc. | 3.19B | -0.11% | 791,074 | - |
| 202 | WRBY | Warby Parker Inc. | 3.17B | 6.61% | 2,846,273 | 890.57M |
| 203 | NHC | National HealthCare Corporation | 3.08B | 3.31% | 143,874 | 1.53B |
| 204 | ITGR | Integer Holdings Corporation | 3.07B | 1.12% | 139,542 | 1.86B |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.07B | 1.08% | 724,807 | 236.00M |
| 206 | ALMS | Alumis Inc. | 2.98B | 1.43% | 718,226 | 8.40M |
| 207 | PRVA | Privia Health Group, Inc. | 2.97B | 0.60% | 464,457 | 2.25B |
| 208 | QURE | uniQure N.V. | 2.96B | -2.55% | 2,763,796 | 18.09M |
| 209 | HTFL | HeartFlow, Inc. | 2.88B | 1.71% | 612,161 | 191.42M |
| 210 | ADPT | Adaptive Biotechnologies Corporation | 2.79B | 4.05% | 2,201,827 | 295.41M |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 2.76B | 0.67% | 804,355 | 225.27M |
| 212 | ELVN | Enliven Therapeutics, Inc. | 2.74B | 0.33% | 1,487,672 | - |
| 213 | GRDN | Guardian Pharmacy Services, Inc. | 2.73B | -0.74% | 359,716 | 1.46B |
| 214 | GRAL | GRAIL, Inc. | 2.72B | 6.61% | 424,586 | 156.12M |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | 0.78% | 208,829 | 535.08M |
| 216 | TMDX | TransMedics Group, Inc. | 2.69B | 6.43% | 1,043,338 | 635.89M |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.69B | 1.64% | 1,566,713 | 670.00M |
| 218 | IRON | Disc Medicine, Inc. | 2.66B | -0.78% | 350,336 | - |
| 219 | DFTX | Definium Therapeutics, Inc. | 2.65B | -0.57% | 910,957 | - |
| 220 | CLOV | Clover Health Investments, Corp. | 2.61B | 3.44% | 4,179,513 | 2.21B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.56B | -0.88% | 501,328 | 865.00K |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.55B | 0.89% | 398,437 | 776.83M |
| 223 | VERA | Vera Therapeutics, Inc. | 2.55B | 1.34% | 421,063 | - |
| 224 | KLRA | Kailera Therapeutics, Inc. | 2.53B | 2.04% | 588,769 | - |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.49B | 2.85% | 255,811 | 229.58M |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.40B | 3.42% | 1,919,597 | - |
| 227 | AXGN | Axogen, Inc. | 2.37B | -0.11% | 683,349 | 238.11M |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.30B | 1.28% | 3,589,791 | 885.72M |
| 229 | PHVS | Pharvaris N.V. | 2.28B | -2.39% | 67,029 | - |
| 230 | BFLY | Butterfly Network, Inc. | 2.27B | 51.66% | 48,618,197 | 102.92M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.25B | 4.04% | 1,241,728 | 3.37B |
| 232 | KOD | Kodiak Sciences Inc. | 2.22B | -0.28% | 367,361 | - |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | 1.19% | 418,298 | 1.09B |
| 234 | NTLA | Intellia Therapeutics, Inc. | 2.14B | 0.99% | 4,002,178 | 66.09M |
| 235 | LMAT | LeMaitre Vascular, Inc. | 2.12B | 0.38% | 216,977 | 256.28M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 1.49% | 635,266 | 298.30M |
| 237 | IMNM | Immunome, Inc. | 2.08B | -0.65% | 618,762 | 4.02M |
| 238 | OCUL | Ocular Therapeutix, Inc. | 2.08B | -1.24% | 4,255,992 | 52.04M |
| 239 | XRAY | DENTSPLY SIRONA Inc. | 2.07B | 3.19% | 2,165,982 | 3.68B |
| 240 | ZLAB | Zai Lab Limited | 2.07B | 3.08% | 771,531 | 453.28M |
| 241 | SEM | Select Medical Holdings Corporation | 2.06B | 0.21% | 380,937 | 5.52B |
| 242 | MLYS | Mineralys Therapeutics, Inc. | 2.05B | -0.96% | 1,828,801 | - |
| 243 | PGNY | Progyny, Inc. | 2.05B | -0.65% | 772,550 | 1.29B |
| 244 | VCEL | Vericel Corporation | 2.03B | 1.41% | 595,341 | 292.09M |
| 245 | BHVN | Biohaven Ltd. | 2.03B | -1.25% | 1,962,324 | - |
| 246 | NKTR | Nektar Therapeutics | 2.02B | -1.87% | 290,127 | 55.63M |
| 247 | NEOG | Neogen Corporation | 2.01B | 3.25% | 875,684 | 870.56M |
| 248 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 2.00% | 594,018 | 66.05M |
| 249 | MBX | MBX Biosciences, Inc. | 1.99B | 0.59% | 417,965 | - |
| 250 | ADMA | ADMA Biologics, Inc. | 1.96B | 0.42% | 1,902,216 | 509.86M |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -0.89% | 178,561 | 899.11M |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.94B | 2.68% | 498,519 | 32.08M |
| 253 | NUVB | Nuvation Bio Inc. | 1.93B | 3.94% | 2,907,071 | 143.05M |
| 254 | ASTH | Astrana Health, Inc. | 1.92B | 1.70% | 205,492 | 3.53B |
| 255 | SGRY | Surgery Partners, Inc. | 1.89B | 2.39% | 567,063 | 3.34B |
| 256 | MESO | Mesoblast Limited | 1.89B | 2.04% | 72,514 | 65.38M |
| 257 | SRPT | Sarepta Therapeutics, Inc. | 1.88B | 4.72% | 1,938,534 | 2.18B |
| 258 | TRLV | Trulieve Cannabis Corp. | 1.87B | 2.86% | 718,876 | 1.17B |
| 259 | MD | Pediatrix Medical Group, Inc. | 1.86B | -1.53% | 593,608 | 1.93B |
| 260 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -0.60% | 126,415 | 1.20B |
| 261 | UFPT | UFP Technologies, Inc. | 1.86B | 5.44% | 157,890 | 608.85M |
| 262 | VRDN | Viridian Therapeutics, Inc. | 1.84B | -0.18% | 1,172,487 | 70.92M |
| 263 | KARD | Kardigan, Inc. | 1.84B | 31.00% | 4,720,790 | - |
| 264 | TSHA | Taysha Gene Therapies, Inc. | 1.83B | 2.99% | 1,293,280 | 7.47M |
| 265 | AGL | agilon health, inc. | 1.82B | 4.42% | 185,974 | 5.82B |
| 266 | GENB | Generate Biomedicines, Inc. | 1.82B | 2.38% | 342,910 | 30.30M |
| 267 | HCM | HUTCHMED (China) Limited | 1.81B | 1.38% | 28,244 | 548.51M |
| 268 | RAPP | Rapport Therapeutics, Inc. | 1.78B | 1.21% | 137,022 | 20.00M |
| 269 | NRIX | Nurix Therapeutics, Inc. | 1.78B | 0.64% | 782,259 | 71.78M |
| 270 | BHC | Bausch Health Companies Inc. | 1.77B | -0.32% | 2,639,526 | 10.53B |
| 271 | NBTX | Nanobiotix S.A. | 1.77B | -0.29% | 47,679 | 38.27M |
| 272 | PLSE | Pulse Biosciences, Inc. | 1.77B | 0.43% | 149,173 | 751.00K |
| 273 | IOVA | Iovance Biotherapeutics, Inc. | 1.77B | 0.64% | 7,070,778 | 285.61M |
| 274 | WGS | GeneDx Holdings Corp. | 1.75B | 4.48% | 343,006 | 442.68M |
| 275 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.74B | 2.89% | 623,249 | -665.00K |
| 276 | OMCL | Omnicell, Inc. | 1.74B | -0.73% | 521,602 | 1.23B |
| 277 | ADUS | Addus HomeCare Corporation | 1.73B | 0.86% | 152,506 | 1.45B |
| 278 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | 2.42% | 1,278,380 | 217.17M |
| 279 | SION | Sionna Therapeutics, Inc. | 1.71B | 2.91% | 276,248 | - |
| 280 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | 3.38% | 14,057,417 | 66.41M |
| 281 | AVAH | Aveanna Healthcare Holdings Inc. | 1.69B | 3.12% | 924,511 | 2.52B |
| 282 | ANIP | ANI Pharmaceuticals, Inc. | 1.69B | -0.94% | 162,637 | 923.71M |
| 283 | ZYME | Zymeworks Inc. | 1.69B | -0.04% | 342,718 | 81.26M |
| 284 | TYRA | Tyra Biosciences, Inc. | 1.68B | -2.65% | 431,221 | - |
| 285 | PGEN | Precigen, Inc. | 1.68B | -0.21% | 2,007,452 | 31.60M |
| 286 | CMPS | COMPASS Pathways plc | 1.68B | 4.27% | 2,461,890 | - |
| 287 | ANAB | AnaptysBio, Inc. | 1.67B | 1.06% | 217,800 | 232.39M |
| 288 | ABCL | AbCellera Biologics Inc. | 1.67B | 0.37% | 5,579,183 | 79.21M |
| 289 | CAPR | Capricor Therapeutics, Inc. | 1.66B | 2.79% | 655,247 | 11.13M |
| 290 | INVA | Innoviva, Inc. | 1.66B | -0.93% | 420,594 | 420.69M |
| 291 | NVCR | NovoCure Limited | 1.65B | -20.22% | 3,145,198 | 674.41M |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.65B | 1.73% | 394,513 | 367.34M |
| 293 | PVLA | Palvella Therapeutics, Inc. | 1.61B | -0.09% | 98,121 | - |
| 294 | URGN | UroGen Pharma Ltd. | 1.60B | 0.27% | 444,940 | 140.49M |
| 295 | SEPN | Septerna, Inc. | 1.60B | -0.98% | 143,676 | 72.26M |
| 296 | HROW | Harrow, Inc. | 1.58B | 1.34% | 741,149 | 268.68M |
| 297 | VIR | Vir Biotechnology, Inc. | 1.57B | -0.22% | 1,407,354 | 65.50M |
| 298 | HCSG | Healthcare Services Group, Inc. | 1.56B | 1.74% | 415,387 | 1.85B |
| 299 | BCAX | Bicara Therapeutics Inc. | 1.54B | 2.27% | 510,759 | - |
| 300 | AAPG | Ascentage Pharma Group International | 1.54B | 0.99% | 11,715 | 82.08M |
| 301 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -1.36% | 718,241 | 42.95M |
| 302 | SLS | SELLAS Life Sciences Group, Inc. | 1.53B | 5.80% | 5,090,230 | - |
| 303 | NVAX | Novavax, Inc. | 1.52B | -2.63% | 3,479,597 | 596.34M |
| 304 | GHRS | GH Research PLC | 1.51B | 1.15% | 281,194 | - |
| 305 | ATAI | AtaiBeckley Inc. | 1.49B | -0.49% | 2,442,903 | 3.49M |
| 306 | ALMR | Alamar Biosciences, Inc. | 1.48B | 5.99% | 124,489 | 87.16M |
| 307 | AVBP | ArriVent BioPharma, Inc. | 1.48B | 1.40% | 275,639 | - |
| 308 | IMCR | Immunocore Holdings plc | 1.46B | 0.47% | 626,955 | 412.81M |
| 309 | ARDX | Ardelyx, Inc. | 1.46B | 1.03% | 2,384,764 | 427.68M |
| 310 | STAA | STAAR Surgical Company | 1.45B | -0.55% | 204,083 | 290.38M |
| 311 | TDOC | Teladoc Health, Inc. | 1.45B | 5.47% | 3,225,781 | 2.51B |
| 312 | NEO | NeoGenomics, Inc. | 1.44B | 6.84% | 5,004,199 | 745.97M |
| 313 | FTRE | Fortrea Holdings Inc. | 1.44B | -0.98% | 1,028,777 | 2.71B |
| 314 | ATRC | AtriCure, Inc. | 1.42B | 3.63% | 599,753 | 552.16M |
| 315 | MLTX | MoonLake Immunotherapeutics | 1.41B | 0.16% | 412,652 | - |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.40B | 1.81% | 327,725 | 20.00M |
| 317 | PRGO | Perrigo Company plc | 1.39B | -0.89% | 2,164,226 | 4.18B |
| 318 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 3.90% | 1,001,260 | 1.64B |
| 319 | SVRA | Savara Inc. | 1.37B | 0.37% | 946,543 | - |
| 320 | INBX | Inhibrx Biosciences, Inc. | 1.35B | -2.12% | 230,061 | 1.30M |
| 321 | DMRA | Damora Therapeutics, Inc. | 1.35B | 2.05% | 158,697 | - |
| 322 | ATEC | Alphatec Holdings, Inc. | 1.34B | 5.83% | 2,605,750 | 787.08M |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.34B | -0.67% | 1,295,723 | 204.73M |
| 324 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 0.92% | 201,259 | - |
| 325 | IMTX | Immatics N.V. | 1.33B | 2.42% | 172,786 | 43.00M |
| 326 | AKTS | Aktis Oncology, Inc. | 1.33B | 2.42% | 347,897 | 8.28M |
| 327 | CDNA | CareDx, Inc. | 1.32B | 8.84% | 602,767 | 412.82M |
| 328 | ARDT | Ardent Health, Inc. | 1.29B | -0.88% | 242,847 | 6.43B |
| 329 | AVLN | Avalyn Pharma Inc. | 1.28B | 4.78% | 270,228 | - |
| 330 | AHCO | AdaptHealth Corp. | 1.28B | 0.94% | 655,749 | 3.29B |
| 331 | PAHC | Phibro Animal Health Corporation | 1.28B | 1.98% | 115,278 | 1.50B |
| 332 | BLFS | BioLife Solutions, Inc. | 1.27B | 1.64% | 487,971 | 101.66M |
| 333 | INNV | InnovAge Holding Corp. | 1.26B | 1.31% | 248,325 | 949.17M |
| 334 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 7.62% | 209,922 | - |
| 335 | ENOV | Enovis Corporation | 1.25B | 4.36% | 615,995 | 2.28B |
| 336 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | 2.77% | 979,693 | 322.02M |
| 337 | ZBIO | Zenas BioPharma, Inc. | 1.22B | 4.04% | 609,449 | 10.00M |
| 338 | ALVO | Alvotech | 1.22B | -0.51% | 742,964 | 562.04M |
| 339 | INSP | Inspire Medical Systems, Inc. | 1.21B | 2.16% | 614,675 | 915.25M |
| 340 | XERS | Xeris Biopharma Holdings, Inc. | 1.21B | 1.30% | 1,053,980 | 314.85M |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.20B | -4.42% | 471,765 | 3.42B |
| 342 | MNKD | MannKind Corporation | 1.19B | -1.40% | 2,161,359 | 360.78M |
| 343 | IRMD | IRADIMED CORPORATION | 1.18B | 1.53% | 92,293 | 86.28M |
| 344 | WVE | Wave Life Sciences Ltd. | 1.17B | 2.61% | 1,901,324 | 71.80M |
| 345 | SDGR | Schrödinger, Inc. | 1.17B | 1.09% | 787,534 | 254.91M |
| 346 | AVNS | Avanos Medical, Inc. | 1.17B | 0.20% | 2,120,061 | 715.90M |
| 347 | PNTG | The Pennant Group, Inc. | 1.16B | -3.30% | 180,584 | 1.02B |
| 348 | KMTS | Kestra Medical Technologies, Ltd. | 1.15B | 2.96% | 221,337 | 83.72M |
| 349 | ABSI | Absci Corporation | 1.14B | 1.53% | 4,336,905 | 1.84M |
| 350 | EYPT | EyePoint, Inc. | 1.13B | 2.36% | 770,036 | 7.61M |
| 351 | AHG | Akso Health Group | 1.12B | 6.50% | 3,512 | 14.84M |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.09B | -0.36% | 169,929 | 796.33M |
| 353 | OPK | OPKO Health, Inc. | 1.08B | 1.06% | 1,946,919 | 581.12M |
| 354 | PSNL | Personalis, Inc. | 1.08B | 5.33% | 1,726,243 | 64.52M |
| 355 | AZTA | Azenta, Inc. | 1.07B | 1.92% | 315,063 | 596.48M |
| 356 | MGTX | MeiraGTx Holdings plc | 1.06B | 10.37% | 1,280,739 | 79.76M |
| 357 | NUTX | Nutex Health Inc. | 1.04B | 3.46% | 80,968 | 879.95M |
| 358 | OMDA | Omada Health, Inc. | 1.04B | 1.51% | 345,640 | 283.30M |
| 359 | TNDM | Tandem Diabetes Care, Inc. | 1.04B | -1.49% | 1,067,622 | 1.03B |
| 360 | JBIO | Jade Biosciences, Inc. | 1.03B | 2.90% | 498,522 | - |
| 361 | AORT | Artivion, Inc. | 1.02B | -1.37% | 374,728 | 458.69M |
| 362 | CRON | Cronos Group Inc. | 1.00B | 0.94% | 914,801 | 159.54M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 998.99M | -1.00% | 581,852 | - |
| 364 | DBVT | DBV Technologies S.A. | 998.84M | -4.85% | 291,645 | 5.74M |
| 365 | CNMD | CONMED Corporation | 979.45M | 1.31% | 419,595 | 1.37B |
| 366 | EVO | Evotec SE | 974.56M | -0.76% | 22,019 | 859.03M |
| 367 | USPH | U.S. Physical Therapy, Inc. | 964.72M | 0.88% | 93,023 | 787.69M |
| 368 | SPTX | Seaport Therapeutics, Inc. | 952.84M | 4.09% | 177,827 | - |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 951.99M | 7.27% | 852,710 | - |
| 370 | XNCR | Xencor, Inc. | 951.98M | 0.47% | 352,035 | 97.36M |
| 371 | SANA | Sana Biotechnology, Inc. | 949.18M | 4.11% | 2,036,834 | - |
| 372 | SPRY | ARS Pharmaceuticals, Inc. | 945.37M | -3.84% | 688,854 | 98.99M |
| 373 | AVR | Anteris Technologies Global Corp. | 927.67M | 0.32% | 770,061 | 1.85M |
| 374 | QDEL | QuidelOrtho Corporation | 917.85M | 2.51% | 811,025 | 2.66B |
| 375 | PHAR | Pharming Group N.V. | 913.52M | 2.29% | 2,830 | 369.49M |
| 376 | BIOA | BioAge Labs, Inc. | 911.73M | 2.60% | 318,008 | 10.32M |
| 377 | ABUS | Arbutus Biopharma Corporation | 905.71M | 3.50% | 1,364,147 | 191.45M |
| 378 | SLBT | SL Science Holding Limited | 901.87M | -12.54% | 394,693 | - |
| 379 | LXRX | Lexicon Pharmaceuticals, Inc. | 899.50M | -0.74% | 1,346,593 | 69.64M |
| 380 | GDRX | GoodRx Holdings, Inc. | 897.49M | 1.53% | 338,384 | 787.89M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 896.98M | 0.41% | 606,001 | - |
| 382 | ETON | Eton Pharmaceuticals, Inc. | 883.40M | -1.56% | 217,236 | 86.93M |
| 383 | PCRX | Pacira BioSciences, Inc. | 881.79M | -1.02% | 195,823 | 734.86M |
| 384 | LMRI | Lumexa Imaging Holdings, Inc. | 874.33M | 3.53% | 381,405 | 1.03B |
| 385 | TALK | Talkspace, Inc. | 871.90M | 0.10% | 2,352,116 | 238.37M |
| 386 | KURA | Kura Oncology, Inc. | 871.76M | 2.61% | 814,508 | 71.64M |
| 387 | CERT | Certara, Inc. | 871.16M | -7.13% | 3,851,737 | 419.75M |
| 388 | ODTX | Odyssey Therapeutics, Inc. | 869.89M | -0.22% | 319,631 | 2.98M |
| 389 | PHAT | Phathom Pharmaceuticals, Inc. | 868.97M | -0.55% | 659,608 | 204.89M |
| 390 | JANX | Janux Therapeutics, Inc. | 864.76M | 0.21% | 407,327 | 13.73M |
| 391 | DRTS | Alpha Tau Medical Ltd. | 863.89M | -0.31% | 442,309 | - |
| 392 | TBPH | Theravance Biopharma, Inc. | 859.39M | -0.24% | 240,700 | 109.78M |
| 393 | LBRX | LB Pharmaceuticals Inc | 857.72M | -0.47% | 325,642 | - |
| 394 | INMD | InMode Ltd. | 843.30M | -0.37% | 268,088 | 374.64M |
| 395 | AMPH | Amphastar Pharmaceuticals, Inc. | 838.21M | -2.06% | 445,961 | 720.53M |
| 396 | REPL | Replimune Group, Inc. | 827.38M | 0.20% | 1,498,671 | - |
| 397 | GERN | Geron Corporation | 821.15M | 4.07% | 14,604,909 | 196.12M |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 814.08M | -1.27% | 1,208,978 | - |
| 399 | ESPR | Esperion Therapeutics, Inc. | 812.20M | -0.47% | 15,723,919 | 418.24M |
| 400 | SLDB | Solid Biosciences Inc. | 811.22M | 12.72% | 5,433,260 | - |
| 401 | ANNX | Annexon, Inc. | 807.74M | -0.20% | 1,653,579 | - |
| 402 | ANRO | Alto Neuroscience, Inc. | 800.84M | 4.73% | 111,922 | - |
| 403 | VOR | Vor Biopharma Inc. | 793.28M | -2.53% | 539,525 | - |
| 404 | AVTX | Avalo Therapeutics, Inc. | 789.53M | -2.47% | 765,942 | 59.00K |
| 405 | DSGN | Design Therapeutics, Inc. | 766.35M | 2.85% | 586,519 | - |
| 406 | ZVRA | Zevra Therapeutics, Inc. | 761.40M | 2.14% | 770,813 | 122.29M |
| 407 | HSTM | HealthStream, Inc. | 753.50M | -0.80% | 88,532 | 311.78M |
| 408 | IVA | Inventiva S.A. | 751.19M | 1.98% | 3,354,427 | 7.94M |
| 409 | OMER | Omeros Corporation | 741.12M | 6.22% | 1,735,769 | 9.89M |
| 410 | EVMN | Evommune, Inc. | 736.22M | -1.02% | 347,669 | 10.00M |
| 411 | BVS | Bioventus Inc. | 730.93M | 2.46% | 340,321 | 576.30M |
| 412 | NNNN | Anbio Biotechnology | 730.79M | 4.98% | 15,046 | 8.65M |
| 413 | GMRS | GMR Solutions Inc. | 730.78M | 12.66% | 970,574 | 5.83B |
| 414 | ALLO | Allogene Therapeutics, Inc. | 711.02M | 5.10% | 3,906,652 | 22.00K |
| 415 | TENX | Tenax Therapeutics, Inc. | 707.13M | 1.18% | 362,497 | - |
| 416 | SIBN | SI-BONE, Inc. | 702.49M | 4.14% | 211,871 | 206.22M |
| 417 | SSII | SS Innovations International, Inc. | 702.46M | 6.69% | 38,481 | 48.47M |
| 418 | CRMD | CorMedix Inc. | 689.98M | 1.44% | 1,264,135 | 400.05M |
| 419 | RLMD | Relmada Therapeutics, Inc. | 688.60M | -0.53% | 620,880 | - |
| 420 | AURA | Aura Biosciences, Inc. | 684.96M | -1.58% | 269,777 | - |
| 421 | CBLL | CeriBell, Inc. | 680.88M | 3.85% | 296,704 | 95.07M |
| 422 | OCS | Oculis Holding AG | 669.10M | -1.95% | 661,163 | 1.40M |
| 423 | CLYM | Climb Bio, Inc. | 659.07M | 1.50% | 705,988 | - |
| 424 | CTMX | CytomX Therapeutics, Inc. | 655.29M | 1.69% | 2,385,058 | 35.54M |
| 425 | IMMX | Immix Biopharma, Inc. | 647.83M | -0.33% | 1,307,497 | - |
| 426 | CSTL | Castle Biosciences, Inc. | 630.86M | 2.72% | 325,774 | 339.92M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 625.69M | 1.36% | 854,203 | 8.37M |
| 428 | SGP | SpyGlass Pharma, Inc. | 624.74M | 2.69% | 51,017 | - |
| 429 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 623.23M | 1.30% | 193,020 | - |
| 430 | TRAX | First Tracks Biotherapeutics, Inc. | 623.18M | -1.71% | 465,691 | - |
| 431 | CADL | Candel Therapeutics, Inc. | 620.60M | 6.01% | 1,448,866 | - |
| 432 | BBNX | Beta Bionics, Inc. | 610.94M | 3.94% | 459,442 | 110.24M |
| 433 | RIGL | Rigel Pharmaceuticals, Inc. | 607.61M | -1.59% | 194,864 | 299.77M |
| 434 | TCMD | Tactile Systems Technology, Inc. | 602.25M | 3.37% | 89,318 | 343.52M |
| 435 | DRUG | Bright Minds Biosciences Inc. | 592.58M | 1.03% | 154,967 | - |
| 436 | CBIO | Crescent Biopharma, Inc. | 587.49M | -2.91% | 68,696 | 11.88M |
| 437 | DNA | Ginkgo Bioworks Holdings, Inc. | 586.61M | 5.03% | 628,324 | 151.40M |
| 438 | IRWD | Ironwood Pharmaceuticals, Inc. | 586.02M | 1.14% | 938,383 | 361.51M |
| 439 | AQST | Aquestive Therapeutics, Inc. | 585.85M | 5.42% | 1,962,118 | 50.27M |
| 440 | PRME | Prime Medicine, Inc. | 585.20M | 2.53% | 2,233,068 | 4.03M |
| 441 | BWAY | BrainsWay Ltd. | 578.01M | 0.49% | 30,299 | 56.22M |
| 442 | PHR | Phreesia, Inc. | 575.47M | -0.43% | 558,765 | 495.59M |
| 443 | TECX | Tectonic Therapeutic, Inc. | 564.75M | -0.43% | 63,427 | - |
| 444 | GYRE | Gyre Therapeutics, Inc. | 562.85M | 1.32% | 44,774 | 117.05M |
| 445 | TLRY | Tilray Brands, Inc. | 561.82M | -0.84% | 2,624,771 | 858.28M |
| 446 | MDXG | MiMedx Group, Inc. | 548.87M | 2.08% | 794,503 | 389.42M |
| 447 | AGMB | AgomAb Therapeutics NV | 543.21M | 9.21% | 104,664 | - |
| 448 | CLPT | ClearPoint Neuro, Inc. | 539.21M | 6.96% | 1,438,779 | 40.61M |
| 449 | PROK | ProKidney Corp. | 539.18M | 2.00% | 230,995 | 889.00K |
| 450 | CERS | Cerus Corporation | 537.99M | 4.47% | 1,573,341 | 216.56M |
| 451 | NPCE | NeuroPace, Inc. | 530.33M | 2.61% | 70,686 | 99.53M |
| 452 | ALT | Altimmune, Inc. | 528.00M | 2.84% | 2,851,401 | 36.00K |
| 453 | RZLT | Rezolute, Inc. | 527.56M | 5.43% | 1,741,360 | - |
| 454 | TOI | The Oncology Institute, Inc. | 526.91M | 0.38% | 939,611 | 545.76M |
| 455 | XOMA | XOMA Royalty Corporation | 525.72M | 0.48% | 39,356 | 48.56M |
| 456 | EIKN | Eikon Therapeutics, Inc. | 522.98M | -0.72% | 106,795 | - |
| 457 | FLGT | Fulgent Genetics, Inc. | 513.77M | 2.20% | 232,738 | 320.35M |
| 458 | VALN | Valneva SE | 511.98M | 0.20% | 5,720 | 180.25M |
| 459 | CTEV | Claritev Corporation | 506.83M | -0.07% | 69,259 | 978.76M |
| 460 | FDMT | 4D Molecular Therapeutics, Inc. | 506.56M | 2.87% | 388,937 | 88.24M |
| 461 | SRTA | Strata Critical Medical, Inc. | 506.18M | 1.04% | 1,244,709 | 228.58M |
| 462 | ACHV | Achieve Life Sciences, Inc. | 506.11M | -8.02% | 1,595,289 | - |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 464 | NGNE | Neurogene Inc. | 499.58M | 2.68% | 107,087 | 925.00K |
| 465 | ANGO | AngioDynamics, Inc. | 499.14M | 2.00% | 174,762 | 313.73M |
| 466 | ARVN | Arvinas, Inc. | 496.81M | 0.39% | 311,087 | 89.40M |
| 467 | CTKB | Cytek Biosciences, Inc. | 495.26M | -3.64% | 1,296,170 | 204.17M |
| 468 | ASMB | Assembly Biosciences, Inc. | 492.56M | 2.92% | 189,516 | 71.10M |
| 469 | EVH | Evolent Health, Inc. | 492.10M | -6.32% | 1,279,708 | 1.89B |
| 470 | KYTX | Kyverna Therapeutics, Inc. | 487.57M | 0.19% | 575,285 | - |
| 471 | STRO | Sutro Biopharma, Inc. | 484.52M | 2.92% | 141,663 | 99.61M |
| 472 | KIDS | OrthoPediatrics Corp. | 478.64M | 2.56% | 56,686 | 243.30M |
| 473 | CABA | Cabaletta Bio, Inc. | 477.75M | 3.17% | 2,648,952 | - |
| 474 | PRTA | Prothena Corporation plc | 472.75M | 6.36% | 395,697 | 57.94M |
| 475 | ARTV | Artiva Biotherapeutics, Inc. | 467.90M | -3.12% | 412,278 | 251.00K |
| 476 | MOBI | Mobia Medical, Inc. | 459.89M | -4.34% | 128,083 | 32.04M |
| 477 | INDP | Indaptus Therapeutics, Inc. | 455.23M | -10.67% | 254,930 | - |
| 478 | CCCC | C4 Therapeutics, Inc. | 450.56M | 3.95% | 1,749,611 | 34.86M |
| 479 | VREX | Varex Imaging Corporation | 446.33M | 3.82% | 253,942 | 857.50M |
| 480 | MNPR | Monopar Therapeutics Inc. | 445.80M | 3.35% | 80,428 | - |
| 481 | OVID | Ovid Therapeutics Inc. | 443.27M | -1.86% | 1,183,536 | 7.12M |
| 482 | CTNM | Contineum Therapeutics, Inc. | 441.91M | -2.80% | 99,060 | - |
| 483 | EOLS | Evolus, Inc. | 440.24M | -0.82% | 294,775 | 301.79M |
| 484 | PACB | Pacific Biosciences of California, Inc. | 436.40M | 4.85% | 2,486,911 | 160.03M |
| 485 | FBRX | Forte Biosciences, Inc. | 435.69M | 1.36% | 82,710 | - |
| 486 | MYGN | Myriad Genetics, Inc. | 431.63M | 4.34% | 862,655 | 829.00M |
| 487 | OCGN | Ocugen, Inc. | 428.23M | 2.85% | 5,004,895 | 4.47M |
| 488 | VTVT | vTv Therapeutics Inc. | 426.76M | 1.39% | 44,551 | 36.84M |
| 489 | KMDA | Kamada Ltd. | 425.65M | 0.14% | 18,505 | 181.68M |
| 490 | WEAV | Weave Communications, Inc. | 420.90M | - | 748,455 | 248.72M |
| 491 | RGNX | REGENXBIO Inc. | 417.72M | 2.28% | 1,154,496 | 87.82M |
| 492 | PRLD | Prelude Therapeutics Incorporated | 415.55M | -3.68% | 174,232 | 16.72M |
| 493 | BNTC | Benitec Biopharma Inc. | 415.00M | 2.37% | 82,341 | - |
| 494 | SGMT | Sagimet Biosciences Inc. | 414.97M | 2.91% | 691,871 | - |
| 495 | IPSC | Century Therapeutics, Inc. | 414.82M | 2.22% | 318,323 | 109.16M |
| 496 | EBS | Emergent BioSolutions Inc. | 414.06M | -1.41% | 489,123 | 676.80M |
| 497 | CYH | Community Health Systems, Inc. | 413.81M | 1.83% | 573,734 | 12.29B |
| 498 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.73M | 0.95% | 383,734 | - |
| 499 | NRC | NRC Health | 410.62M | 2.65% | 219,585 | 138.64M |
| 500 | CCRN | Cross Country Healthcare, Inc. | 408.53M | 0.04% | 1,061,718 | 1.00B |